Public Sector Data Availability and Use

The Productivity Commission is undertaking an Inquiry into the availability and use of public data. Research Australia’s submission in response to the Issues Paper emphasises the importance of improved access to public data as a means of facilitating Australian health and medical research. It highlights the importance of linked datasets and identifies a number of cultural and legislative barriers to the greater use of data for research purposes. It also provides some case studies and makes some recommendations for improvement.

Data Availability and Use

GSK Award for Research Excellence open for nominations

36th year of prestigious $80,000 research grant

Nominations for GSK’s Award for Research Excellence (ARE) are now open until 4 July. The longstanding award seeks to assist Australian research heroes by providing the winner with an $80,000 grant to support their research journey.

The GSK Award for Research Excellence is one of the most prestigious available to the Australian medical research community. It has been awarded since 1980 to recognise outstanding achievements in medical research and facilities career development with potential importance to human health and Australian research.

Continue reading “GSK Award for Research Excellence open for nominations”

Consultation on MRFF Strategy and Priorities

The initial phase of the MRFF Advisory Board’s consultation on the Strategy and Priorities closed on 6 June 2016.

 Research Australia drew on the extensive consultation process we undertook with our broad membership and alliance partners to respond to the consultation. We provided a submission in response to the Strategy and seven specific proposals in relation to Priorities for the MRFF. Lodged as eight separate submissions, they have been collated in a single document.

R A submissions to MRFF Consultations on Strategy and Priorities

 

New expert report to guide Medical Research Future Fund

Media Release: Monday 6 June, 2016

A new report from the health and medical sector says the Medical Research Future Fund (MRFF) needs to prioritise closing gaps between health research, health practice and the health economy.

Translating Research for a sustainable future comprehensively brings together the positions of 160 of Australia’s leading health and medical research organisations, companies and personnel.

The review, contributed to by prominent researchers, universities, and businesses in the field, outlines the sector’s view on priorities for the MRFF over the next two and five years.

Continue reading “New expert report to guide Medical Research Future Fund”

New Leaders to Strengthen the Alliance of Australian Health and Medical Researchers

Media Release: Wednesday 11 May 2016

Decades’ worth of highly-specialised experience is being added to the leadership of Research Australia, with the appointment of a new CEO and four new Board members.

Research Australia is an alliance of 160 members and supporters advocating for health and medical research in Australia.

Continue reading “New Leaders to Strengthen the Alliance of Australian Health and Medical Researchers”

Australian take on International Clinical Trials Day

Media Release: Friday 20 May 2016

A clinical trial investigating reducing risk of neonatal infections related to pre-labour ruptured membranes, has been awarded the inaugural Trial of the Year Award 2016 by the Australian Clinical Trials Alliance (ACTA).

Professor Johnathan Morris, chief investigator, this morning accepted the award on behalf of the trial investigators at the Clinical Trials 2016 Breakfast and Award Ceremony this morning from Health Minister Sussan Ley.

Continue reading “Australian take on International Clinical Trials Day”

Medical Research Future Fund Strategies and Priorities – responding to the consultation

Research Australia Member Webinar: MRFF Strategies and Priorities – responding to the consultation

Download Presentation > MRFF Webinar Presentation

The MRFF provides a unique opportunity to transform Australian health and medical research and innovation.

The Health Minister has appointed an Advisory Board of eminent Australians to develop a five-year Strategy for the MRFF and the funding priorities for the first two years.

Continue reading “Medical Research Future Fund Strategies and Priorities – responding to the consultation”

Medical Research Future Fund consultations commence

The Australian Medical Research Advisory Board supporting the Medical Research Future Fund (MRFF) has announced the commencement of a two stage consultation process on the five-year Strategy and two-year Priorities. The first stage is a public call for submissions.

A consultation Paper and more information in relation to making a submission are available on the Department of Health website. Submissions close on 6 June 2016.  This will be followed by a second stage of targeted consultations to be held in July.

Continue reading “Medical Research Future Fund consultations commence”

Nanoscience Facility is a $150M Investment in Australian Ingenuity

Media Release: Tuesday 3 May 2016

Recently the University of Sydney officially opened the Australian Institute for Nanoscale Science and Technology.

Nadia Levin is CEO of Research Australia, the peak group representing 160 members advocating for health and medical research in Australia. In response to requests for comment, she said:

“In 1965, Intel co-founder Gordon Moore correctly predicted exponential growth in computing technology, with computer power to double in capacity, and halve in price, every two years.

“Common computers since that time have gone from the size of houses to rooms to watches and beyond, and their capabilities today are at levels considered sci-fi even at the turn of this century.

Continue reading “Nanoscience Facility is a $150M Investment in Australian Ingenuity”

Federal Budget a Combination of Treatments, Placebos and Nocebos for Health and Medical Research

Media Release: Wednesday 4 May 2016

Research Australia, which represents 160 health and medical research organisations, has described last night’s budget as mixed bag – with some wins, some losses and some more detail required.

“The Federal Government is making all of the right noises when it comes to innovation, health and research, and it is pleasing that they remain on the agenda,” said CEO Nadia Levin.

“The budget would be described by my members as a combination of ‘treatments, placebos and nocebos’, and the challenge for government is to back it up with funding.”

Continue reading “Federal Budget a Combination of Treatments, Placebos and Nocebos for Health and Medical Research”